---
document_datetime: 2023-09-21 22:10:22
document_pages: 11
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/matever-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: matever-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 6.5023421
conversion_datetime: 2025-12-28 00:05:56.923597
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Matever

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0043/G            | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a | 27/06/2023                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                       |            |            |                 | new additional   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|------------------|
| IB/0042   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                                                                                                                                                                                                                                                                           | 09/06/2022 | 18/11/2022 | SmPC and PL     | the MAH          |
| IB/0041/G | This was an application for a group of variations. B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished | 29/11/2021 | 18/11/2022 | Annex II and PL |                  |

<div style=\"page-break-after: always\"></div>

|           | product - Addition of a new test(s) and limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |            |             |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| N/0040    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 29/09/2021 | 18/11/2022 | PL          |
| IAIN/0039 | B.II.a.3.a.1 - Changes in the composition (excipients) of the finished product - Changes in components of the flavouring or colouring system - Addition , deletion or replacement                                                                                                                                                                                                                                                                                                                                                                                            | 06/08/2021 | n/a        |             |
| IB/0038   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                 | 01/06/2021 | 17/06/2021 | SmPC and PL |
| IB/0037/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 13/01/2021 | 17/06/2021 | SmPC and PL |

<div style=\"page-break-after: always\"></div>

| IA/0036/G   | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate an already approved manufacturer   | 09/12/2020   | n/a        |             | from   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|--------|
| N/0035      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 24/06/2020   | 24/09/2020 | PL          |        |
| IB/0034     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 30/03/2020   | 24/09/2020 | SmPC and PL |        |

<div style=\"page-break-after: always\"></div>

|           | - Implementation of change(s) for which NO additional data is required to be submitted by MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |                                  | product new the   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------|
| IB/0033   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                   | 04/10/2019 | 24/09/2020 | SmPC, Annex II, Labelling and PL |                   |
| II/0032   | B.II.e.1.b.2 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Sterile medicinal products and biological/immunological medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                 | 14/06/2019 | n/a        |                                  |                   |
| IB/0031/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a | 24/10/2018 | 21/10/2019 | SmPC, Labelling and PL           |                   |

<div style=\"page-break-after: always\"></div>

|           | generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                   |            |            |             |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| N/0030    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 02/07/2018 | 21/10/2019 | PL          |
| N/0029    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 31/05/2017 | 25/01/2018 | PL          |
| N/0028    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 30/03/2017 | 25/01/2018 | PL          |
| IB/0027   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 16/01/2017 | 25/01/2018 | SmPC and PL |
| IB/0026   | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                   | 05/12/2016 | n/a        |             |
| IAIN/0025 | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)                                                          | 10/10/2016 | n/a        |             |

<div style=\"page-break-after: always\"></div>

| N/0024    | Update of the package leaflet with revised contact details of the local representatives for Lithuania, Estonia and Latvia, for the film-coated tablets presentations (EU/1/11/711/001-029). Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 07/07/2016   | 25/01/2018   | PL                               |                                                                                                                                                                                                                                                                        |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0023    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                        | 28/04/2016   | 29/06/2016   | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Matever in the approved indications remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IAIN/0022 | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                                                        | 13/01/2016   | n/a          |                                  |                                                                                                                                                                                                                                                                        |
| IAIN/0021 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                | 12/05/2015   | n/a          |                                  |                                                                                                                                                                                                                                                                        |
| II/0018   | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range                                                                                                                                            | 26/03/2015   | n/a          |                                  |                                                                                                                                                                                                                                                                        |
| N/0020    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                               | 26/02/2015   | 29/06/2016   | PL                               |                                                                                                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

| IB/0019/G   | This was an application for a group of variations. B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.4.a - Change in the batch size (including batch   | 12/01/2015   | n/a        |                       | size ranges) of the finished   |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------------|--------------------------------|
| N/0017      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 02/10/2014   | 15/01/2015 | PL                    |                                |
|             | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 05/05/2014   | 15/01/2015 | SmPC, Annex II and PL | IB/0016/G                      |

<div style=\"page-break-after: always\"></div>

|           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |            |             | the MAH   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------|
| N/0015    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                               | 01/04/2014 | 15/01/2015 | PL          |           |
| IB/0013   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   | 19/12/2013 | 15/01/2015 | SmPC and PL |           |
| IAIN/0011 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                | 21/10/2013 | n/a        |             |           |
| N/0010    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                               | 28/08/2013 | 15/01/2015 | PL          |           |
| N/0009    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                               | 21/05/2013 | 15/01/2015 | PL          |           |
| N/0008    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                               | 06/02/2013 | 15/01/2015 | PL          |           |

<div style=\"page-break-after: always\"></div>

| IB/0006 N/0004   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)   | 24/08/2012 22/05/2012   | 28/09/2012 28/09/2012   | SmPC, Labelling and PL PL   | Section 4.8 of the SmPC was updated in order to add 'panic attack' as an undesirable effect following the cumulative review of the safety data for Keppra (II-131). The Package Leaflet was updated in accordance. In addition, editorial changes were made to sections 2 and 4.1 of the SmPC. Section 2 of the Package Leaflet was updated in order to change the description of the quantity of the sodium excipient in Matever concentrate for solution for infusion. Moreover, the description of pancytopenia, erythema multiforme, Stevens-Johnsons syndrome and toxic epidermal necrolysis in section 4 of the package Leaflet was updated. The PI was brought in line with the latest QRD template, version 8 and details for local representatives in IT and NL were updated in Annex III B.   |
|------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------|-------------------------|-----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0003          | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                    | 04/04/2012              | 28/09/2012              | SmPC and PL                 | This variation is to update section 4.8 of the SmPC and section 4 of the PIL as a consequence of the adoption by the CHMP of safety variations related to significant modifications of the Summary of Product Characteristics (SmPC) due in particular to new quality, pre-clinical, clinical or pharmacovigilance data to Matever's reference medicinal product Keppra.                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IAIN/0002        | C.I.9.i - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) to a DDPS following the assessment of the same DDPS in                                                                                                                                                                                             | 06/01/2012              | n/a                     |                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

<div style=\"page-break-after: always\"></div>

|        | relation to another medicinal product of the same MAH                                                                   |            |            |    |
|--------|-------------------------------------------------------------------------------------------------------------------------|------------|------------|----|
| N/0001 | The Marketing Authorisation Holder (MAH) took the opportunity to update details of local representatives in Annex IIIB. | 22/11/2011 | 28/09/2012 | PL |
|        | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                        |            |            |    |